Study on fragile newborns challenges current practices
Thursday, June 20, 2013 - 16:30
in Health & Medicine
One of the largest clinical trials done in infants with congenital heart diseases shows that the increasingly common practice of using the drug clopidogrel (Plavix) to reduce shunt-related blood flow issues is not effective in the dose studied.